Several recently published systematic reviews of randomized controlled trials have reported beneficial effects of berry consumption on markers of cardiovascular disease risk.
Berries are amongst the healthiest of fruits and may provide many potential health benefits including supporting cardiovascular health, improved metabolic health and even potentially offering protection against cancer.
The health benefits of berries are largely thought to be the result of the many beneficial bioactive phyto-chemicals they contain such as phenolic compounds, anthocyanins, ellagic acid and many others.
These phenolic compounds possess a wide range of biological activities including antioxidant, anti-inflammatory, antiplatelet activities and even anti-cancer properties.
Some of my favorite types of berries include blueberries, strawberries, raspberries, cranberries, blackberries and goji berries.
Let’s take a look at some of the recently published systematic reviews with meta-analysis on berry consumption and cardiovascular disease risk factors.
Berries & Cardiovascular Disease Risk Factors
A number of studies have now found that berry consumption has a positive impact on many traditional cardiovascular disease risk factors such as protecting against hypertension by lowering blood pressure, improving endothelial function, improvements in glycemic control and blood lipids, amongst other benefits.
Intake of berries has also been shown to have a beneficial effect on cholesterol levels by reducing total cholesterol, LDL cholesterol, triglycerides, while increasing the level of HDL cholesterol.
A systematic review of randomized controlled trials on the effect of Berry-Based Food Interventions on Markers of Cardiovascular and Metabolic Health published 2018 evaluated 23 randomized controlled trials.
The systematic review of randomized controlled trials concluded:
Our evaluation of the literature indicates that more than two-thirds of high-quality trials have reported beneficial effects of berry consumption on markers of CVD risk. This systematic review contributes moderate to strong evidence for the inclusion of berries as part of a cardioprotective diet. 
Another systematic review published in 2018 with meta-analysis and trial sequential analysis of randomized controlled trials aimed to clarify the effects of the consumption of berries on cardiovascular disease (CVD) risk factors.
The systematic review concluded:
It was observed that the intake of berries reduces TC, LDL, TG, and BP while increasing the level of HDL, suggesting a beneficial effect on the control of CVDs’ risk factors. Thus, the intake of berries as nutraceuticals or functional foods could be suggested for the prevention and control of CVDs. 
 The Effect of Berry-Based Food Interventions on Markers of Cardiovascular and Metabolic Health: A Systematic Review of Randomized Controlled Trials.
 Association between berries intake and cardiovascular diseases risk factors: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials.
The information in this article has not been evaluated by the FDA and should not be used to diagnose, cure or treat any disease, implied or otherwise.